TARSONSNSETarsons Products LimitedMediumNeutral
Announced Tue, 14 Apr · 18:40 IST

Tarsons Products Limited has informed the Exchange about change in Management

Management Changes View source PDF

TARSONS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.6%1-day move
₹201.90
prior close
₹206.48
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.6-1.4-0.9+4.6+5.5+6.5+7.0+4.8+3.2+12.7+4.5+1.5+48.0
Up moveDown movePending
AI summary

Tarsons Products Limited has announced the appointment of Mr. Mani Kalyan Dusi as Head - Revenue (India & APAC), designated as Senior Management Personnel (SMP). He is expected to join the company on or before May 20, 2026. Mr. Dusi brings over 18 years of experience in life sciences, pharmaceuticals, and academic sectors across the APAC region. He is currently serving as Associate Director and Head - Commercial Enablement (APAC) at Merck Life Science. The appointment was made based on the recommendation of the Nomination & Remuneration Committee. This is a senior management-level appointment rather than a director-level or KMP appointment.

Likely market impact

This appointment strengthens the company's revenue leadership team in the India and APAC region. As a Senior Management Personnel appointment, it does not directly impact shareholding or require shareholder approval, but signals focus on commercial expansion in the APAC market.